A 28-year-old nulliparous woman presents for follow-up with the chief complaint of persistent dysmenorrhea that was progressing and severe dyspareunia. At age 16, she first reported heavy menstrual ...
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU) Treatments for ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results